Target Price | $6.00 |
Price | $4.50 |
Potential |
33.33%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Champions Oncology, Inc. price target 2025.
The average Champions Oncology, Inc. target price is $6.00.
This is
33.33%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend Champions Oncology, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Champions Oncology, Inc. stock has an average upside potential 2025 of
33.33%
register free of charge
|
Apr '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 50.16 | 53.73 |
6.89% | 7.11% | |
EBITDA Margin | -10.07% | 6.76% |
333.88% | 167.14% |
1 Analyst has issued a sales forecast Champions Oncology, Inc. 2025 . The average Champions Oncology, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Champions Oncology, Inc. 2025 . The average Champions Oncology, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Apr '24 |
2025 Estimates |
|
---|---|---|
EV/Sales | 1.22 |
Based on analysts' sales estimates for 2025, the Champions Oncology, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Champions Oncology, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.